PharmCADD uses AI-based protein structure prediction algorithms, MD simulation, and Quantum calculation to enable faster drug design. Founded in 2019, PharmCADD is backed by investors that include KTB Network, DSC Investment, KDB Capital, KB Securities, and SD Group and is headquartered in Busan.